3.8 million eligible, and the biggest group doesn't know it
Published 2026-07-21
KFF's eligibility analysis of the GLP-1 Bridge lands at roughly 3.8 million Medicare beneficiaries meeting the program's criteria — about 8% of Part D enrollment, derived from some 9.7 million meeting clinical thresholds minus those routed to other coverage paths by diabetes, sleep apnea, or MASH diagnoses.
The composition of that number is the story. The program's most visible tier — BMI 35+, qualifying alone — is not its largest. The quiet giant is Tier 3: BMI 27 or higher plus prediabetes, a prior heart attack or stroke, or symptomatic peripheral artery disease. Prediabetes alone affects roughly half of adults over 65, mostly undiagnosed, and BMI 27 describes weights most people consider merely 'a little over' — 167 pounds at 5'6", 188 at 5'10".
The practical takeaway: the modal eligible beneficiary is someone who has never considered a weight-loss medication program because they don't think of themselves as heavy enough — and whose qualifying condition sits unexamined in last year's bloodwork. A BMI check and an A1c test are the two-step screen, and both take minutes. That, more than any policy detail, is what the 3.8 million figure means.